History


October 2018

Obtained the qualification of "National High-tech Enterprise";

July 2018

Huibang joined hands with Licheng Capital to complete the first round of equity financing;

2017

The 2017 China Innovation and Entrepreneurship Competition won the first place in Hefei and the second place in Anhui;

September 2017

Obtained the product registration certificate of "Dry Fluorescence Immunoassay Analyzer";

February 2017

Hefei Huibang Biotechnology Co., Ltd., a subsidiary of Huibang Holdings, was established for sales and promotion in the Anhui market; a marketing center was set up in Chengdu to be responsible for product sales in the southwest and northwest regions;

July 2016

The first product came out: urine iodine quantitative analysis system (urine iodine detection kit + urine iodine quantitative analyzer), which was sold and promoted in the national market; in the same month, Huibang's national market sales strategic layout: Beijing Tianjian Yuan Biotechnology Co., Ltd. became the vanguard of Huibang Biotechnology, responsible for product sales in North China and Central China;

January 2014

Huibang obtained the medical device production license, and then the company entered the research and development stage;

May 2013

Anhui Huibang Bioengineering Co., Ltd. was established;
< 12 >